Senior insider sale
Chief Medical Officer at BIOAGE LABS, INC. — senior position signals high conviction
$1.02M
94.33K shares
What this filing means
RUBIN PAUL D plans to sell 94.33K shares of BIOAGE LABS, INC. valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2026ACC: 0001959173-26-000027
Officer· Chief Medical Officer
Since Mar 2026
94.33K
Shares to sell
$1.02M
Approx. market value
7.43K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Options Granted - 05/29/2022
Cash
1/2/2026
2KOptions Granted - 07/01/2020
Cash
1/2/2026
5.43KTotal acquired7.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2026 | Options Granted - 05/29/2022 Cash | 2K | — |
1/2/2026 | Options Granted - 07/01/2020 Cash | 5.43K | — |
| Total | 7.43K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
18K
Market value
$216.0K
12/9/2025
—Completed
Units to sell
68.90K
Market value
$701.9K
12/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.43K
Market value
$99.7K
1/2/2026
Total
Units
94.33K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/9/2025 | 18K | $216.0K | — | Completed |
12/4/2025 | 68.90K | $701.9K | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 7.43K | $99.7K | NASDAQ | Planned |
| Total | 94.33K | $1.02M | ||